Markets
After being neutral on Apple’s stock since 2018, here’s why one analyst changed his tune
[unable to retrieve full-text content]An analyst who had spent more than six years on the sidelines ...View More
Pfizer, Genmab get full FDA approval for cervical-cancer drug
[unable to retrieve full-text content]Pfizer and Genmab on Monday said they had received full approv ...View More
Peacock raising prices by $2 a month ahead of Summer Olympics
[unable to retrieve full-text content]Peacock is raising prices again, a year after its last price h ...View More
Paramount CEO Bob Bakish is stepping down, to be replaced by 3 executives
[unable to retrieve full-text content]Media and entertainment giant Paramount Global on Monday said ...View More
AMC’s stock registers biggest decline in a month after preliminary first-quarter results
[unable to retrieve full-text content]Shares of AMC Entertainment Holdings Inc. ended Monday’s sessi ...View More
AT&T’s stock is misunderstood. Here are five reasons Barclays says it can soar.
[unable to retrieve full-text content]AT&T’s decisions in recent years look better than those made b ...View More
Coursera, Chegg stocks fall after weaker guidance for both edtech companies
[unable to retrieve full-text content]Shares of Coursera Inc. and Chegg Inc. fell in the after-hours ...View More
AMD’s AI story has lost some shine. Can earnings brighten the picture?
[unable to retrieve full-text content]The past few months haven’t been so easy on the Nvidia Corp. w ...View More
Guns, abortion, transgender rights: The political issues Trump and Biden voters care about most when deciding where to live
[unable to retrieve full-text content]It’s not just about good schools and affordable homes — voters ...View More
The battle between athleisure and wider-leg pants is here. That means more trouble for Lululemon, analyst says.
[unable to retrieve full-text content]After the skinny jean’s nearly two-decade reign, retailers and ...View More
